Publication & Citation Trends
Publications
0 total
Clinical events after interruption of anticoagulation in patients with atrial fibrillation: An analysis from the ENGAGE AF-TIMI 48 trial.
Cited by 26
Semantic Scholar
Genetics and the clinical response to warfarin and edoxaban: findings from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Cited by 168
Semantic Scholar
Prognostic Implications of Low Level Cardiac Troponin Elevation Using High‐Sensitivity Cardiac Troponin T OA
Cited by 21
Semantic Scholar
Abstract 17121: Reduction in Total Cardiovascular Events With Long-term Use of Ticagrelor in Patients With Prior Myocardial Infarction in the PEGASUS-TIMI 54 Trial
Cited by 2
Semantic Scholar
Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial.
Cited by 391
Semantic Scholar
PERIOPERATIVE ADVERSE OUTCOMES IN PATIENTS WITH ATRIAL FIBRILLATION TAKING EDOXABAN OR WARFARIN: ANALYSIS OF THE ENGAGE AF-TIMI 48 TRIAL OA
Cited by 14
Semantic Scholar
Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48. OA
Cited by 199
Semantic Scholar
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.
Cited by 4,311
Semantic Scholar
Research Topics
Atrial Fibrillation Management and Outcomes
(11)
Cardiac Arrhythmias and Treatments
(5)
Venous Thromboembolism Diagnosis and Management
(4)
Acute Ischemic Stroke Management
(2)
Coronary Interventions and Diagnostics
(1)
Affiliations
Brigham and Women's Hospital
Harvard University
Massachusetts General Hospital
IQVIA (United States)
Thrombolysis in Myocardial Infarction Study Group